Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a kind of hematologic malignancy in which overall survival (OS) may be affected by many factors such as the patient's age, gender, conventional karyotyping (CK) findings, lactate dehydrogenase (LDH) concentration, white blood cells (WBC) count, and bone marrow bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdulkader Memeh, Abdel Galil Ghriwati, , Khalid Khanji, Ibrahim Kebbe War
Format: Article
Language:English
Published: Zagazig University, Faculty of Pharmacy 2023-07-01
Series:Zagazig Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://zjps.journals.ekb.eg/article_306238_fec23a2b7b4639e733d7d08255b963c7.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849415457498464256
author Abdulkader Memeh
Abdel Galil Ghriwati
, Khalid Khanji
Ibrahim Kebbe War
author_facet Abdulkader Memeh
Abdel Galil Ghriwati
, Khalid Khanji
Ibrahim Kebbe War
author_sort Abdulkader Memeh
collection DOAJ
description Acute myeloid leukemia (AML) is a kind of hematologic malignancy in which overall survival (OS) may be affected by many factors such as the patient's age, gender, conventional karyotyping (CK) findings, lactate dehydrogenase (LDH) concentration, white blood cells (WBC) count, and bone marrow blast (BMB) percentage at diagnosis. In this study, we aimed to evaluate the prognostic significance of those characteristics on OS at diagnosis. The current study included 98 AML patients who have been examined for cytology, CK, and immunophenotyping. The average patient’s age was 39 years old. In addition, around 56% of patients had a chromosomal abnormality. Furthermore, the patients with LDH levels higher than 450 IU/L, WBC counts over 50 X109/L, BMB% more than 50%, and AML-M0 had a shorter OS compared to other groups. However, the results suggested that CK, LDH, WBC count, and BMB% might be used as good prognostic tests in patients with AML at diagnosis.
format Article
id doaj-art-e8e7754574c7460b882b98709e8c27f9
institution Kabale University
issn 1110-5089
2356-9786
language English
publishDate 2023-07-01
publisher Zagazig University, Faculty of Pharmacy
record_format Article
series Zagazig Journal of Pharmaceutical Sciences
spelling doaj-art-e8e7754574c7460b882b98709e8c27f92025-08-20T03:33:31ZengZagazig University, Faculty of PharmacyZagazig Journal of Pharmaceutical Sciences1110-50892356-97862023-07-013211427https://doi.org/10.21608/zjps.2023.204428.1046Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid LeukemiaAbdulkader Memeh0 Abdel Galil Ghriwati1, Khalid Khanji2Ibrahim Kebbe War3Dept. of Biotechnology Engineering, Faculty of Technology Engineering, Aleppo University, Aleppo, SyriaDept. of Biotechnology Engineering, Faculty of Technology Engineering, Aleppo University, Aleppo, SyriaDept. of Hematology, Faculty of Medicine, Aleppo University, Aleppo, SyriaDept. of Biochemistry and Clinical Pharmacy, Faculty of Pharmacy, Ebla Private University, Aleppo, SyriaAcute myeloid leukemia (AML) is a kind of hematologic malignancy in which overall survival (OS) may be affected by many factors such as the patient's age, gender, conventional karyotyping (CK) findings, lactate dehydrogenase (LDH) concentration, white blood cells (WBC) count, and bone marrow blast (BMB) percentage at diagnosis. In this study, we aimed to evaluate the prognostic significance of those characteristics on OS at diagnosis. The current study included 98 AML patients who have been examined for cytology, CK, and immunophenotyping. The average patient’s age was 39 years old. In addition, around 56% of patients had a chromosomal abnormality. Furthermore, the patients with LDH levels higher than 450 IU/L, WBC counts over 50 X109/L, BMB% more than 50%, and AML-M0 had a shorter OS compared to other groups. However, the results suggested that CK, LDH, WBC count, and BMB% might be used as good prognostic tests in patients with AML at diagnosis. https://zjps.journals.ekb.eg/article_306238_fec23a2b7b4639e733d7d08255b963c7.pdfacute myeloid leukemiakaryotypingldhwbcbone marrow percentage
spellingShingle Abdulkader Memeh
Abdel Galil Ghriwati
, Khalid Khanji
Ibrahim Kebbe War
Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
Zagazig Journal of Pharmaceutical Sciences
acute myeloid leukemia
karyotyping
ldh
wbc
bone marrow percentage
title Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
title_full Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
title_fullStr Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
title_full_unstemmed Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
title_short Evaluation of Conventional Karyotyping, Lactate Dehydrogenase Levels, White Blood Cells count, and Bone Marrow Blast Percentage as Good Prognostic Tests in Patients Diagnosed with Acute Myeloid Leukemia
title_sort evaluation of conventional karyotyping lactate dehydrogenase levels white blood cells count and bone marrow blast percentage as good prognostic tests in patients diagnosed with acute myeloid leukemia
topic acute myeloid leukemia
karyotyping
ldh
wbc
bone marrow percentage
url https://zjps.journals.ekb.eg/article_306238_fec23a2b7b4639e733d7d08255b963c7.pdf
work_keys_str_mv AT abdulkadermemeh evaluationofconventionalkaryotypinglactatedehydrogenaselevelswhitebloodcellscountandbonemarrowblastpercentageasgoodprognostictestsinpatientsdiagnosedwithacutemyeloidleukemia
AT abdelgalilghriwati evaluationofconventionalkaryotypinglactatedehydrogenaselevelswhitebloodcellscountandbonemarrowblastpercentageasgoodprognostictestsinpatientsdiagnosedwithacutemyeloidleukemia
AT khalidkhanji evaluationofconventionalkaryotypinglactatedehydrogenaselevelswhitebloodcellscountandbonemarrowblastpercentageasgoodprognostictestsinpatientsdiagnosedwithacutemyeloidleukemia
AT ibrahimkebbewar evaluationofconventionalkaryotypinglactatedehydrogenaselevelswhitebloodcellscountandbonemarrowblastpercentageasgoodprognostictestsinpatientsdiagnosedwithacutemyeloidleukemia